China Pharma (NYSE:CPHI) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of China Pharma (NYSE:CPHI) in a research note issued on Friday. The brokerage set a “hold” rating on the stock.

China Pharma Trading Up 11.2 %

CPHI opened at $0.24 on Friday. The company has a current ratio of 0.84, a quick ratio of 0.24 and a debt-to-equity ratio of 0.19. The business’s 50-day moving average is $0.21 and its two-hundred day moving average is $0.27. China Pharma has a 1 year low of $0.17 and a 1 year high of $1.21.

China Pharma (NYSE:CPHI) last issued its quarterly earnings data on Wednesday, August 14th. The company reported ($0.09) earnings per share (EPS) for the quarter. The firm had revenue of $0.93 million during the quarter. China Pharma had a negative return on equity of 60.19% and a negative net margin of 70.47%.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.